Roche CEO Expects Pharma Portfolio to Deliver Sales Growth Through 2030
1 week ago
4
The drugmaker’s on-market pharma portfolio, unneurotic with drugs for lupus, bosom crab and aggregate sclerosis, should offset generic contention until 2030, Chief Executive Thomas Schinecker said.